Futures
Access hundreds of perpetual contracts
CFD
Gold
One platform for global traditional assets
Event Contracts
New
Predict price moves and seize opportunities
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
CFD
Stock CFD derivatives
Stocks
Invest directly in popular stocks and ETFs worldwide
Stock Futures
High leverage, 24/7 trading
Stock Options
New
Popular stock options, flexible leverage
Stocks Activities
Trade popular stocks and unlock generous airdrops
Tokenized Stocks
Backed by real stock assets
IPO Access
Unlock full access to global stock IPOs
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
IPO Access
Anthropic
Unlock full access to global stock IPOs
Futures Points
Earn futures points and claim airdrop rewards
Promotions
Others
Help Center
Find FAQs and help guides
Partners
Grow with the champions
Proof of Reserves
Gate promises 100% proof of reserves
Proof of Security (PoSEC)
Full cold storage for user funds
Gate Guard
Account Protection Plan
Gate Vault
Keep your assets secure
Licenses
Regulatory licenses, registrations, and approvals
#GateIPOAccessAnthropic $ANTHROPIC
Anthropic's AI Growth Is Impressive, But Is the IPO Valuation Too Ambitious?
Anthropic is entering one of the most closely watched moments in the AI industry. Its proposed Nasdaq IPO under the ticker ANT, with an indicative price range of $70–$78 per share, has attracted considerable attention. But I believe the more important question is not how popular Claude has become. It is whether the company's financial performance can justify the valuation investors are being asked to accept.
There is a big difference between investing in a promising technology and investing in that technology at the right price.
The Growth Story Is Difficult to Ignore
Anthropic's preliminary IPO prospectus reports an impressive business expansion.
For Q3 2026, the company reported:
$17 billion in quarterly revenue.
More than 12x year-over-year revenue growth.
Over 11,900 customers generating at least $100,000 in trailing 12-month revenue.
A 15% adjusted operating margin.
These figures suggest that AI demand is moving beyond experimentation. Businesses are increasingly paying for AI models, coding assistance, enterprise workflows and API-based applications.
This is particularly important because recurring commercial usage is a stronger business signal than social media attention or temporary product excitement.
However, there is another side to these numbers.
The Cost of Building Advanced AI
Anthropic's Q3 financial disclosures also show a 58% revenue share going toward compute and infrastructure expenses. Its reported operating margin was negative 3%, despite a positive 15% adjusted operating margin.
The company also reported a $23.3 billion net loss, including a substantial $21.9 billion non-cash accounting charge related to changes in the fair value of convertible notes, derivative liabilities and SAFEs.
This distinction matters. The reported net loss should not be interpreted as an equivalent cash operating loss, but it should not be ignored either.
Advanced AI requires enormous computing capacity, energy, infrastructure and research investment. Anthropic's prospectus also discloses approximately $900.9 billion in aggregate compute and infrastructure purchase commitments and leases.
These commitments extend across multiple years, so they are not an immediate single-period expense. Nevertheless, they demonstrate the scale of capital required to maintain growth.
Is the Proposed Valuation Reasonable?
The $70–$78 indicative share price sounds relatively accessible when considered individually. But share price alone tells us very little about whether a company is cheap or expensive.
Gate's indicative valuation figures are approximately $920 billion–$1.02 trillion based on issued shares, rising to $1.26–$1.4 trillion on a fully diluted basis.
That is an enormous valuation, even for a company experiencing rapid AI adoption.
Investors are effectively paying for a substantial amount of future growth. Anthropic must continue expanding enterprise adoption, improving compute efficiency and converting technological progress into sustainable profitability.
If those expectations are exceeded, the long-term business outlook could remain compelling. If growth slows, infrastructure costs increase or pricing pressure reduces margins, the market could reassess the valuation quickly.
Understanding Gate IPO Access
There is another important distinction: subscribing does not mean receiving guaranteed shares.
Gate IPO Access allows eligible users to submit indicative subscriptions using USDT, starting from 100 USDT. Successfully allocated shares are credited to Gate Stock Accounts.
The allocation is proportional to subscription participation, and Gate specifies underwriting service fees of 5% on cumulative investment up to 50,000 USDT and 10% on the amount above that threshold.
The indicative subscription is not a guaranteed allocation. Funds are also subject to the subscription-period arrangements, while the final IPO price and actual market price can differ from the indicative range.
These details matter because participation costs, allocation size and post-listing price movements all influence the actual investment outcome.
My Take
I see Anthropic as an important company in the commercial development of AI, and its reported revenue growth is genuinely impressive.
However, a strong company is not automatically a good investment at every valuation.
Personally, I would focus more on the final IPO pricing, operating margins, compute spending and the market's reaction after listing than on the excitement surrounding the subscription itself.
The opportunity is interesting, but patience and valuation discipline matter just as much as identifying a promising company early.
Not financial advice.
Would you consider Anthropic at a fully diluted valuation approaching $1.4 trillion, or would you prefer to wait for actual public-market price discovery before making a decision?